Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Debt: 2017-2021

Historic Total Debt for AC Immune (ACIU) over the last 4 years, with Dec 2021 value amounting to $21.5 million.

  • AC Immune's Total Debt was N/A to $21.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $21.5 million, marking a year-over-year change of. This contributed to the annual value of $21.7 million for FY2021, which is N/A change from last year.
  • Latest data reveals that AC Immune reported Total Debt of $21.5 million as of Q4 2021, which was up 7,609.91% from -$285,714 recorded in Q3 2020.
  • AC Immune's Total Debt's 5-year high stood at $21.5 million during Q4 2021, with a 5-year trough of -$285,714 in Q3 2020.
  • Over the past 3 years, AC Immune's median Total Debt value was $151,181 (recorded in 2019), while the average stood at $2.8 million.
  • Per our database at Business Quant, AC Immune's Total Debt skyrocketed by 122,707.93% in 2019 and then plummeted by 46,883.13% in 2020.
  • Over the past 5 years, AC Immune's Total Debt (Quarterly) stood at $500,708 in 2017, then rose by 3.95% to $520,504 in 2018, then grew by 26.56% to $658,770 in 2019, then plummeted by 194.68% to -$285,714 in 2020, then reached $21.5 million in 2021.
  • Its Total Debt stands at $21.5 million for Q4 2021, versus -$285,714 for Q3 2020 and -$272,945 for Q2 2020.